COX‐2/PTGS2 ‐targeted herbal‐derived oligonucleotide drug HQi ‐ sRNA ‐2 was effective in spontaneous mouse lung cancer model
IUBMB Life · 2024
DOI: 10.1002/iub.2858 ↗Kurz gefasst
Fachartikel in der Zeitschrift IUBMB Life, 2024. Verfasst von Yexuan Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry, Institute of Basic Medical Sciences, Chinese Academ…. Hauptthemen laut MEDLINE: Cyclooxygenase 2, Lung Neoplasms, Cell Proliferation, Apoptosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: The CAMS Endowment Fund, National Natural Science Foundation of China, Overseas Expertise Introduction Project for Discipline Innovation.
Abstract (Originalsprache)
In 2020, the number of deaths caused by lung cancer worldwide reached 1,796,144, making it the leading cause of cancer‐related deaths. Cyclooxygenase‐2/prostaglandin endoperoxide synthase 2 ( COX‐2/PTGS2 ) is overexpressed in lung cancer, which promotes tumor proliferation, invasion, angiogenesis, and resistance to apoptosis. Here, we report that the oligonucleotide drug HQi‐sRNA‐2 from Traditional Chinese Medicine Huangqin targeting COX‐2/PTGS2 significantly inhibited proliferation, migration, and invasion and induced apoptosis in the human lung cancer cell line NCI‐H460. Oral delivery of HQi‐sRNA‐2 bencaosomes prolonged survival, reduced tumor burden, and maintained weight in a spontaneous mouse lung cancer model. Compared with paclitaxel, HQi‐sRNA‐2 may be less toxic and have approximately equal efficacy in reducing tumor burden. Our previous studies reported that herbal small RNAs (sRNAs) are functional medical components. Our data suggest that sphingosine (d18:1)‐HQi‐sRNA‐2 bencaosomes, targeting COX‐2/PTGS2 and downregulating the PI3K and AKT signaling pathways, may provide novel therapeutics for lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
ORCID-Profile: Chengyu Jiang
Förderung
- The CAMS Endowment Fund
- National Natural Science Foundation of China
- Overseas Expertise Introduction Project for Discipline Innovation
- State Key Laboratory Special Fund
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
- Fundamental Research Funds for Central Universities
Zitieren
APA
Lin, Y., Sun, N., Liu, D., Yang, X., Dong, Y., & Jiang, C. (2024). COX‐2/PTGS2 ‐targeted herbal‐derived oligonucleotide drug HQi ‐ sRNA ‐2 was effective in spontaneous mouse lung cancer model. IUBMB Life. https://doi.org/10.1002/iub.2858
Vancouver
Lin Y, Sun N, Liu D, Yang X, Dong Y, Jiang C. COX‐2/PTGS2 ‐targeted herbal‐derived oligonucleotide drug HQi ‐ sRNA ‐2 was effective in spontaneous mouse lung cancer model. IUBMB Life. 2024. doi:10.1002/iub.2858
BibTeX
@article{Lin2024,
author = {Lin, Yexuan and Sun, Na and Liu, Dengyuan and Yang, Xinmeng and Dong, Yixin and Jiang, Chengyu},
title = {COX‐2/PTGS2 ‐targeted herbal‐derived oligonucleotide drug HQi ‐ sRNA ‐2 was effective in spontaneous mouse lung cancer model},
journal = {IUBMB Life},
year = {2024},
doi = {10.1002/iub.2858}
}
EUVIMED